Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: Comparative molecular analysis of epithelial and mesenchymal components

Human Pathology

Volumn 29, Issue 1, 1998, Pages 82-87

  Kounelis, S ^a   Jones, M W ^a   Papadaki, H ^a   Bakker, A ^a   Swalsky, P ^a   Finkelstein, S D ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Female genital tract carcinosarcomas; Histogenesis; Malignant mixed mullerian tumors; Mutation; P53; Tumor suppressor gene

Indexed keywords

PROTEIN P53;

ALLELE; ARTICLE; CANCER CLASSIFICATION; CARCINOSARCOMA; CLINICAL ARTICLE; FEMALE; FEMALE GENITAL TRACT CANCER; GENE MUTATION; GENOTYPE; HISTOGENESIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; MUELLERIAN DUCT; POINT MUTATION; POLYMERASE CHAIN REACTION; TOPOGRAPHY;

EID: 0031964464     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(98)90394-X     Document Type: Article

References (47)

1. HJ Norris HB Taylor Mesenchymal tumors of the uterus. III. A clinical and pathologic study of 31 carcinosarcomas Cancer 94 1966 1459 1465
2. HJ Norris E Roth HB Taylor Mesenchymal tumors of the uterus. II. A clinical and pathologic study of 31 mixed mesodermal tumors Obstet Gynecol 28 1966 57 63
3. MMK Macasaet M Waxman RG Fzuchter Prognostic factors in malignant mesodermal (mullerian) mixed tumors of the uterus Gynecol Oncol 20 1985 32 42
4. S Compel SG Silverberg Pathology in Gynecology and Obstetrics ed 3 1985 Lippincott Philadelphia, PA 249 260
5. P Clement R Scully Uterine tumors with mixed epithelial and mesenchymal elements Semin Diagn Pathol 5 1988 199 222
6. SG Silverberg FJ Major JA Blessing Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus: A Gynecologic Oncology Group pathology study of 203 cases Int J Gynecol Pathol 9 1990 1 19
7. W Schweizer R Demopoulos U Beller Prognostic factors for malignant mixed mullerian tumors of the uterus Int J Gynecol Pathol 9 1990 129 136
8. KY Terada TL Johnson M Hopkins Clinicopathologic features of ovarian mixed mesodermal tumors and carcinosarcomas Gynecol Oncol 32 1989 228 232
9. D Boucher B Tetu Morphologic prognostic factors of malignant mixed mullerian tumors of the ovary: A clinicopathologic study of 15 cases In J Gynecol Pathol 13 1994 22 28
10. C Zaloudek NJ Norris Mesenchymal tumors of the uterus RJ Kurman Blaustein's Pathology of the Female Genital Tract ed 3 1987 Springer Verlag New York, NY 373
11. PB Clement Tumors with mixed epithelial and mesenchymal elements Hum Pathol 22 1991 786 791
12. P Bitterman BK Chun RJ Kurman The significance of epithelial differentiation in mixed mesodermal tumors of the uterus: A clinicopathologic and immunohistochemical study Am J Surg Pathol 14 1990 317 328
13. JJ Sreenan WR Hart Carcinosarcomas of the female genital tract: A pathologic study of 29 metastatic tumors: Further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis Am J Surg Pathol 19 1995 666 674
14. SG Silverberg Histological classification of tumors and related lesions of the uterine corpus International Gynecologic Cancer Society 5 1991 8 (abstr)
15. K Geisinger DJ Dabbs RB Marshall Malignant mixed mullerian tumors An ultrastructural and immunohistochemical analysis with histogenetic considerations ed 4 Cancer 59 1987 1781 1790
16. MT Chung K Mukai S Teshima Expression of various antigens by different components of uterine mixed mullerian tumors Acta Pathol Jpn 38 1988 35 45
17. P Bitterman BK Chun RJ Kurman Uterine carcinosarcomas: A clinicopathologic and immunohistochemical study providing evidence that these are biphasic carcinomas Lab Invest 58 1988 10A (abstr)
18. JM Meis WD Lawrence The immunohistochemical profile of malignant mixed mullerian tumor: Overlap with endometrial carcinoma Am J Clin Pathol 94 1990 1 7
19. C Zaloudek HJ Norris Mesenchymal tumors of the uterus RJ Kurman Blaustein's Pathology of the Female Genital Tract ed 4 1994 Springer-Verlag New York, NY 487 528
20. MJ Costa R Khan R Judd Carcinosarcoma (malignant mixed mullerian [mesodermal] tumor) of the uterus and ovary: Correlation of clinical, pathologic and immunohistochemical features in 29 cases Arch Pathol Lab Med 115 1991 583 590
21. E George JC Manivel LP Dehner Malignant mixed mullerian tumors: An immunohistochemical study of 47 cases with histogenetic considerations and clinical correlation Hum Pathol 22 1991 215 223
22. PA De Brito SG Silverberg JM Orenstein Carcinosarcoma (malignant mixed mullerian [mesodermal] tumor) of the female genital tract: Immunohistochemical and ultrastructural analysis of 28 cases Hum Pathol 24 1993 132 142
23. HE Auerbach VA Livolsi MJ Merino Malignant mixed mullerian tumors of the uterus: An immunohistochemical study Int J Gynecol Pathol 7 1988 123 130
24. M Emoto H Iwasaki M Kikuchi Two cell lines established from mixed mullerian tumors of the uterus: Morphologic immunocytochemical and cytogenetic analysis Cancer 69 1992 1759 1768
25. I Gorai C Doi H Minaguchi Establishment and characterization of carcinosarcoma cell line of the human uterus Cancer 71 1993 775 786
26. A Berchuck MF Kohler JR Mocks The p53 tumor suppressor gene frequently is altered in gynecologic cancers Am J Obstet Gynecol 170 1994 246 252
27. FS Liu MF Kohler JR Mocks Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas Obstet Gynecol 83 1994 118 124
28. MJ Costa J Vogelsang LJ Young p53 gene mutation in female genital tract carcinosarcomas (malignant mixed mullerian tumors): A clinicopathologic study of 74 cases Mod Pathol 7 1994 619 627
29. F Mayall K Rutty F Campbell p53 immunostaining suggests that uterine carcinosarcomas are monoclonal Histopathology 24 1994 211 214
30. SD Finkelstein R Sayegh S Christensen Genotypic classification and colorectal adenocarcinoma Cancer 71 1993 3827 3838
31. SD Finkelstein R Przygodzki VE Pricolo K-ras-2 topographic genotyping of pancreatic adenocarcinomas Arch Surg 129 1994 367 373
32. H Papadaki SD Finkelstein S Kounelis The role of p53 mutation and protein expression in primary and recurrent adenoid cystic carcinoma Hum Pathol 27 1996 567 572
33. T-T Wu L Barnes A Bakker K-ras-2 and p-53 genotyping in intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses Mod Pathol 9 1996 199 204
34. S Kounelis A Kanbour-Shakir H Papadaki Relationship of p53 point mutation genotype to immunohistochemical staining and clinical behavior in ovarian epithelial malignancy 1996 (in press)
35. H Papadaki S Kounelis SB Kapadia Relationship of p53 gene alterations with tumor progression and recurrence in olfactory neuroblastoma Am J Surg Pathol 20 1996 715 721
36. F Gorstein TL Anderson Malignant mixed mesodermal tumors: Carcinoma, sarcoma or both? Hum Pathol 22 1991 207 209
37. R Meyer Mischgeschwiste des uterus: die Komplizierten Tumoren F Herke O Lubarsch HandBuch der Speziellen Pathologischen Anatomie und Histologie 1930 Julius Springer Berlin 412 415
38. J Varela-Duran LE Nochomovitz KA Prem Post irradiation mixed mullerian tumors of the uterus: A comparative clinicopathologic study Cancer 45 1980 1625 1631
39. RF Meredith OR Eisert Z Kara An excess of uterine sarcomas after pelvic irradiation Cancer 58 1986 2003 2007
40. GC Hartman Regeneration of the monkey uterus after surgical removal of the endometrium and accidental endometriosis West J Surg Obstet Gynecol 52 1944 87 98
41. HA Padykula LG Coles WC Okulicz The basal is of the primate endometrium: A functional germinal compartment Biol Reprod 40 1989 681 690
42. RP Colombi Sarcomatoid carcinomas of the female genital tract (malignant mixed mullerian tumors) Semin Diagn Pathol 10 1993 169 175
43. E George TJ Lillemoe LB Twiggs Malignant mixed mullerian tumors versus high-grade endometrial carcinoma and aggressive variants of endometrial carcinoma: A comparative analysis of survival Int J Gynecol Pathol 14 1995 39 44
44. MJ Costa J Walls Epidermal growth factor receptor and c-erbB-2 oncoprotein expression in female genital tract carcinosarcomas (malignant mixed mullerian tumors) Cancer 77 1996 533 542
45. MD Jeffers JA Richmond EM Macaulay Overexpression of the c-myc protooncogene frequently in uterine sarcomas Mod Pathol 8 1995 701 704
46. A Krigman A Elbendazy JR Merks Glandular and stromal overexpression of p53 in mixed malignant mesodermal tumors (MMMT): An argument for clonal origin Mod Pathol 92A 1995 532 (abstr)
47. SM Kennedy C Macgeogh R Jaffe Overexpression of the oncoprotein p53 in primary hepatic tumors of childhood does not correlate with gene mutation Hum Pathol 25 1994 438 442